TD Waterhouse Canada Inc. Lowers Stock Holdings in Stryker Corporation $SYK

TD Waterhouse Canada Inc. decreased its position in shares of Stryker Corporation (NYSE:SYK) by 1.5% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 171,354 shares of the medical technology company’s stock after selling 2,552 shares during the period. TD Waterhouse Canada Inc.’s holdings in Stryker were worth $60,217,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Venturi Wealth Management LLC boosted its holdings in shares of Stryker by 1.4% during the third quarter. Venturi Wealth Management LLC now owns 1,904 shares of the medical technology company’s stock worth $704,000 after purchasing an additional 27 shares during the period. Patriot Financial Group Insurance Agency LLC boosted its holdings in shares of Stryker by 3.9% during the third quarter. Patriot Financial Group Insurance Agency LLC now owns 745 shares of the medical technology company’s stock worth $275,000 after purchasing an additional 28 shares during the period. Wolff Wiese Magana LLC boosted its holdings in shares of Stryker by 2.3% during the third quarter. Wolff Wiese Magana LLC now owns 1,271 shares of the medical technology company’s stock worth $470,000 after purchasing an additional 28 shares during the period. Lantz Financial LLC boosted its holdings in shares of Stryker by 5.0% during the third quarter. Lantz Financial LLC now owns 608 shares of the medical technology company’s stock worth $225,000 after purchasing an additional 29 shares during the period. Finally, Stonebridge Capital Advisors LLC boosted its holdings in shares of Stryker by 0.4% during the third quarter. Stonebridge Capital Advisors LLC now owns 7,198 shares of the medical technology company’s stock worth $2,661,000 after purchasing an additional 29 shares during the period. 77.09% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Stryker news, Director Ronda E. Stryker sold 250,000 shares of the firm’s stock in a transaction dated Wednesday, February 4th. The shares were sold at an average price of $362.92, for a total value of $90,730,000.00. Following the completion of the sale, the director directly owned 2,457,331 shares in the company, valued at $891,814,566.52. This trade represents a 9.23% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 4.60% of the stock is owned by company insiders.

Analyst Ratings Changes

SYK has been the subject of a number of analyst reports. Weiss Ratings reiterated a “hold (c+)” rating on shares of Stryker in a report on Monday, December 22nd. The Goldman Sachs Group dropped their target price on shares of Stryker from $403.00 to $357.00 and set a “neutral” rating for the company in a report on Thursday, April 9th. Sanford C. Bernstein increased their target price on shares of Stryker from $450.00 to $465.00 and gave the stock an “outperform” rating in a report on Friday, January 9th. Leerink Partners initiated coverage on shares of Stryker in a report on Monday, April 13th. They set an “outperform” rating and a $410.00 target price for the company. Finally, Jefferies Financial Group reiterated a “buy” rating and set a $465.00 target price on shares of Stryker in a report on Wednesday, March 4th. Fifteen analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Stryker has a consensus rating of “Moderate Buy” and a consensus target price of $421.11.

Stryker Stock Performance

Shares of SYK opened at $343.09 on Monday. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.89 and a quick ratio of 1.21. Stryker Corporation has a one year low of $319.32 and a one year high of $404.87. The company has a 50-day simple moving average of $352.97 and a two-hundred day simple moving average of $359.51. The firm has a market capitalization of $131.40 billion, a PE ratio of 40.84, a price-to-earnings-growth ratio of 2.01 and a beta of 0.92.

Stryker (NYSE:SYK) last issued its quarterly earnings data on Thursday, January 29th. The medical technology company reported $4.47 EPS for the quarter, topping the consensus estimate of $4.40 by $0.07. Stryker had a net margin of 12.92% and a return on equity of 24.41%. The business had revenue of $7.17 billion during the quarter, compared to analyst estimates of $7.12 billion. During the same period last year, the business posted $4.01 earnings per share. Stryker’s quarterly revenue was up 11.4% compared to the same quarter last year. On average, analysts anticipate that Stryker Corporation will post 13.47 EPS for the current fiscal year.

Stryker Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, April 30th. Shareholders of record on Tuesday, March 31st will be issued a $0.88 dividend. The ex-dividend date is Tuesday, March 31st. This represents a $3.52 annualized dividend and a yield of 1.0%. Stryker’s dividend payout ratio (DPR) is 41.90%.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.